Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol M Artlett

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Clinical Chemistry|February 1, 2003
Detection of microchimeric cells in the peripheral blood of nonpregnant women is enhanced by magnetic cell sorting before PCRLori A Cox, Ronald C Ramos, Tara N Dennis, et al.
Arthritis and Rheumatism|September 18, 2003
HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individualsCarol M Artlett, Terrence P O'Hanlon, Ana M Lopez, et al.
Arthritis and Rheumatism|July 28, 2011
The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosisCarol M Artlett, Sihem Sassi-Gaha, Judy L Rieger, et al.
Arthritis and Rheumatism|August 31, 2004
Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skinSergio A Jiménez, Carol M Artlett, Nora Sandorfi, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|October 6, 2009
Two dicarbonyl compounds, 3-deoxyglucosone and methylglyoxal, differentially modulate dermal fibroblastsSihem Sassi-Gaha, Danielle T Loughlin, Frank Kappler, et al.
Antimicrobial Agents and Chemotherapy|February 1, 2012
NLRP3 inflammasome is a target for development of broad-spectrum anti-infective drugsJames D Thacker, Brian J Balin, Denah M Appelt, et al.
Brain Research|September 9, 2008
Receptor for advanced glycation end products and neuronal deficit in the fatal brain edema of diabetic ketoacidosisWilliam H Hoffman, Carol M Artlett, Weixian Zhang, et al.
Dermatology (Basel, Switzerland)|December 18, 2004
Chronic graft-versus-host-disease-like dermopathy in a child with CD4+ cell microchimerismLutz Kowalzick, Carol M Artlett, Karin Thoss, et al.
Clinical Immunology (Orlando, Fla.)|August 14, 2002
Increased microchimeric CD4+ T lymphocytes in peripheral blood from women with systemic sclerosisCarol M Artlett, Lori A Cox, Ronald C Ramos, et al.
Experimental and Molecular Pathology|May 24, 2017
Markers of immune-mediated inflammation in the brains of young adults and adolescents with type 1 diabetes and fatal diabetic ketoacidosis. Is there a difference?William H Hoffman, Carol M Artlett, Dallas Boodhoo, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Clinical Chemistry|February 1, 2003
Detection of microchimeric cells in the peripheral blood of nonpregnant women is enhanced by magnetic cell sorting before PCRLori A Cox, Ronald C Ramos, Tara N Dennis, et al.
Arthritis and Rheumatism|September 18, 2003
HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individualsCarol M Artlett, Terrence P O'Hanlon, Ana M Lopez, et al.
Arthritis and Rheumatism|July 28, 2011
The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosisCarol M Artlett, Sihem Sassi-Gaha, Judy L Rieger, et al.
Arthritis and Rheumatism|August 31, 2004
Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skinSergio A Jiménez, Carol M Artlett, Nora Sandorfi, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|October 6, 2009
Two dicarbonyl compounds, 3-deoxyglucosone and methylglyoxal, differentially modulate dermal fibroblastsSihem Sassi-Gaha, Danielle T Loughlin, Frank Kappler, et al.
Antimicrobial Agents and Chemotherapy|February 1, 2012
NLRP3 inflammasome is a target for development of broad-spectrum anti-infective drugsJames D Thacker, Brian J Balin, Denah M Appelt, et al.
Brain Research|September 9, 2008
Receptor for advanced glycation end products and neuronal deficit in the fatal brain edema of diabetic ketoacidosisWilliam H Hoffman, Carol M Artlett, Weixian Zhang, et al.
Dermatology (Basel, Switzerland)|December 18, 2004
Chronic graft-versus-host-disease-like dermopathy in a child with CD4+ cell microchimerismLutz Kowalzick, Carol M Artlett, Karin Thoss, et al.
Clinical Immunology (Orlando, Fla.)|August 14, 2002
Increased microchimeric CD4+ T lymphocytes in peripheral blood from women with systemic sclerosisCarol M Artlett, Lori A Cox, Ronald C Ramos, et al.
Experimental and Molecular Pathology|May 24, 2017
Markers of immune-mediated inflammation in the brains of young adults and adolescents with type 1 diabetes and fatal diabetic ketoacidosis. Is there a difference?William H Hoffman, Carol M Artlett, Dallas Boodhoo, et al.
Pageof 6